Atrioventricular block in the newborn period Authors: Yuval Bitterman, Elizabeth Anne Stephenson Published: 2025 Test your knowledge! Take an interactive quiz related to this article: https://www.heartrhythmcasereports.com/content/quiz_archive Test your knowledge! Take an interactive quiz related to this article: https://www.heartrhythmcasereports.com/content/quiz_archive Introduction Congenital atrioventricular block (AVB) is a rare condition affecting 1 in 14,000–20,000 births.1 In the absence of congenital heart disease, the etiology is most frequently immune-based, thought to be connected to maternal anti-Ro antibodies.2 Patients exhibit fetal bradycardia, classically starting after the second trimester.1,2 The combination of fetal bradycardia, which can be significant, and myocardial inflammation leading to endocardial fibroelastosis together can lead to fetal hydrops and even fetal demise. Postnatally, the typical presentation is with complete heart block and junctional escape with highly variable rates, and these rates typically determine the need for support and subsequent permanent pacemaker (PPM) implantation.1,2 The current guidelines put emphasis on the average heart rate, determination of the type of escape rhythm, and the appearance of symptoms or long pauses.3 However, there are additional clinical features that may affect decision making regarding pacing. Here we present a case of congenital heart block with an atypical presentation in fetal and neonatal life and an unusual response to common bradycardia medical management. We will use this unusual case to discuss current management guidelines and the importance of evaluating and understanding the reliability of an escape rhythm. Case report A patient was referred from another hospital owing to bradycardia. In his history, he was noted to have an irregular heart rate from 24 weeks of gestation, but no further workup was done. Parents are nonconsanguineous, and during pregnancy, the mother was treated with acetylsalicylic acid and a selective serotonin reuptake inhibitor. The mother had a normal echocardiogram and electrocardiogram (ECG) performed 10 years before the pregnancy. The family history is otherwise negative for congenital heart disease, sudden cardiac death, or autoimmune disease. The mother was seen owing to vaginal bleeding at 37 weeks and 2 days of gestation; labor was induced a day later because of the bleeding and an irregular fetal heart rate. After birth, the patient was vigorous with good Apgar scores. However, over the next few days, he developed episodic bradycardia down to 55–60 beats/min (bpm) that became more frequent, alongside a decreasing trend in the average heart rate. An ECG done at that time showed sinus rhythm with 2:1 AVB with a normal corrected QT interval (360–410 ms) and QRS duration without ST changes. He remained hemodynamically stable throughout these events but, owing to the worsening trend in heart rate and increasing frequency of episodic bradycardia, he was transferred to the cardiac intensive care unit in our hospital 1 week later. Before transfer, he had an episode of sinus rhythm with 2:1 atrioventricular (AV) conduction resulting in a ventricular rate of 45 bpm that was associated with poor peripheral perfusion; thus, an isoproterenol infusion was commenced with titration up to 0.06 μG/kg/min. An ECG on arrival showed sinus rhythm with second-degree AVB in a 2:1 and 3:2 pattern with aberrant conduction of the second beat (Figure 1). The echocardiogram showed normal biventricular systolic function with no evidence of endocardial fibroelastosis or wall motion abnormalities. The flow and size of the proximal coronary system were normal. There were no other anatomic abnormalities.Figure 1ECG on arrival. A 12-lead ECG upon arrival of the patient, while being treated with isoproterenol infusion at a rate of 0.06 μG/kg/min. The ECG demonstrates sinus rhythm with a second-degree type 2 atrioventricular block in a 2:1 and 3:2 pattern with aberrant conduction of the second beat. QTc measurement during the most stable ventricular rhythm is normal (360 ms). P waves are marked by black arrows. PR segments were normal and unchanged in the conducted beats. ECG = electrocardiogram; QTc = corrected QT. ECG on arrival. A 12-lead ECG upon arrival of the patient, while being treated with isoproterenol infusion at a rate of 0.06 μG/kg/min. The ECG demonstrates sinus rhythm with a second-degree type 2 atrioventricular block in a 2:1 and 3:2 pattern with aberrant conduction of the second beat. QTc measurement during the most stable ventricular rhythm is normal (360 ms). P waves are marked by black arrows. PR segments were normal and unchanged in the conducted beats. ECG = electrocardiogram; QTc = corrected QT. Initial investigations for suspected neonatal lupus erythematosus revealed thrombocytopenia that promptly resolved and no other changes in blood work or clinical manifestations suggestive of neonatal lupus erythematosus. Autoantibodies were positive for anti-Ro52 and anti-Ro60 (titers were 1:1127 and >1:1375, respectively). Antinuclear antibody antigen was also positive (speckled, titer 1:640). The mother also had positive anti-Ro52 and anti-Ro60 antibodies. Owing to a lack of echo abnormalities and other system involvement, he was not treated with steroids or immunoglobulins. The patient exhibited rate-related aberrancy suspicious for an infra-Hisian conduction abnormality and worsening of AV conduction at higher atrial rates. AV conduction ranged from 3:2 at slower atrial rates and times of lower stress to 3:1 at higher sinus rates and stress. Isoproterenol was weaned off with improved conduction (Figures 2 and 3). Consistent with this, at times of stress, when his atrial rate increased, his ventricular rate paradoxically decreased and peripheral perfusion worsened. This raised a concern that in the future his escape rhythm would be unreliable, and he underwent epicardial pacemaker insertion on day of life 7 with implantation of a bipolar ventricular lead on the left ventricular apex. The pacemaker was programmed at VVI 100 bpm. Unsurprisingly, he was reliant on the pacemaker in the early postoperative period while he had underlying sinus tachycardia, and was almost exclusively paced, after which his conduction seemed to improve. He had an uncomplicated postoperative course and was discharged on day of life 11. His predischarge Holter examination showed a predominantly ventricular paced rhythm. A pacemaker check showed an underlying sinus rhythm with right bundle branch block and 2:1 and 3:2 AV conduction. He had short runs of 1:1 conduction seen when he dropped his atrial rates to 100–113 bpm. A repeat Holter at the age of 4 weeks again showed predominantly sinus rhythm with varying grades of second-degree AVB, including episodic 2:1 AV conduction, sometimes demonstrating aberrant conduction. Fifteen percent of beats were ventricular paced (programmed VVI 100), with a typical atrial rate of 75–90 bpm with a higher grade of AVB at higher atrial rates.Figure 2A 12-lead ECG after isoproterenol was weaned off. There is an atrial rate of 110 bpm with 1:1 atrioventricular conduction. bpm = beats/min; ECG = electrocardiogram.Figure 3Ventricular rate during and after isoproterenol. Heart rate (ventricular rate) graph showing heart rate on isoproterenol infusion at a rate of 0.06 μG/kg/min and after isoproterenol infusion was weaned off. A 12-lead ECG after isoproterenol was weaned off. There is an atrial rate of 110 bpm with 1:1 atrioventricular conduction. bpm = beats/min; ECG = electrocardiogram. Ventricular rate during and after isoproterenol. Heart rate (ventricular rate) graph showing heart rate on isoproterenol infusion at a rate of 0.06 μG/kg/min and after isoproterenol infusion was weaned off. Owing to his initial unusual presentation, we performed genetic testing of genes associated with conduction system disturbances. Next-generation DNA sequencing and copy number variation examination of DES, EMD, GAA, GLA, LMNA, NKX2.5, SCN1B, SCN10A, TBX5, SCN5A, and TRMP4 genes did not reveal any abnormalities (CTGT Genetic Testing, Allentown, PA). Discussion The differential diagnosis of etiologies of congenital heart block includes autoimmune, genetic, and drug-related reasons. Autoimmune congenital complete heart block (CCHB) comprises 90%–95% of cases in a structurally normal heart.1,4 A detailed history for possible drug exposures is important, but, in our case, it did not reveal any potential culprits. Long QT syndrome can present with AVB and should be suspected especially when a 2:1 AVB pattern exists.5 Scrutiny of the QT segments in repeated ECGs, during times of nonaberrated 1:1 conduction, did not reveal QT prolongation. In an atypical presentation, genetic testing for genes previously known to be associated with conduction system abnormalities is worthwhile. In our case, this was ultimately unrevealing (see above). Finally, based on the positive neonatal and maternal serologies, the presumed etiology of heart block in our case fits an autoimmune-mediated heart block. Commonly, patients with autoimmune AVB will present with CCHB. The typical escape rhythm in these cases is junctional and is fairly consistent, with slow change in rate over time. Owing to a reliable escape rhythm, many patients will be hemodynamically stable on presentation, and rapid fluctuations are extremely unusual. The initial assessment of patients in CCHB will include heart rate monitoring to establish the average heart rate, acknowledging that this can change over the first days and weeks of life, as the neurohormonal milieu changes. Patients who are born prematurely (especially prematurity <35 weeks) are at a higher risk of comorbidities, pacemaker need, and mortality.1,4,6 The initial presentation of our patient with an irregular heart rate during fetal life is also noteworthy. Autoimmune heart block can manifest during pregnancy and even after birth because maternal antibodies are still present.1 However, although AVB grade might worsen, it does not usually manifest with heart rate irregularity.1,2 For this reason, we completed genetic testing as mentioned earlier. We would postulate that in this case, as was the case postnatally, the irregularity stemmed from rate-dependent infra-Hisian AVB. Another important consideration regarding fetal diagnosis relates to the guarded outcomes of extremely premature newborns with CCHB who were induced owing to “fetal bradycardia.”6 Prenatal diagnosis can allow for treatment with prenatal steroids, prevent unnecessary induction, and prepare for delivery in the ideal setting.2,7 The usual initial noninvasive treatment for congenital heart block includes isoproterenol, which typically increases the junctional escape rate. However, isoproterenol can also unmask infra-Hisian conduction disturbances.8,9 In our patient, although increasing doses of isoproterenol increased the sinoatrial rate, the resultant ventricular rate paradoxically decreased owing to worsening of the infra-Hisian block (Figure 3). This situation carries a risk of instability at times of stress, such as the perioperative period. As expected, our patient exhibited profound instability of ventricular rate during the stress of the immediate postoperative period. These decreases in ventricular rate were accompanied by a decrease in blood pressure. Accordingly, during the subsequent 48 hours after pacemaker implantation, he was almost exclusively paced to preserve a ventricular rate of 100 bpm for hemodynamic stability. Current guidelines for PPM implantation state that an average rate of 50 bpm or less would constitute a class I indication for PPM implantation (level of evidence C).3 Other class I indications include symptomatic bradycardia, wide QRS escape rhythm, complex ventricular ectopy, or ventricular dysfunction. In the absence of symptoms, an average heart rate of <50 bpm can be used as a class 1 indication (albeit with a lesser level of evidence, B). The guidelines clearly state in relation to this indication that heart rate is not the sole criterion for implantation given that symptoms can occur at higher heart rates. There are 3 more indications, aimed at infants older than 1 year or adolescents. In our patient, who was symptomatic and had a less reliable escape rhythm, and because the typical temporizing noninvasive medical treatment of isoproterenol paradoxically worsened the bradycardia, we moved forward with pacemaker implantation. Because the lower ventricular rates were episodic rather than continuous, the average heart rate would not have met the typical indication of less than 50 bpm. However, without a pacemaker backup, patients with infra-Hisian block are prone to episodic severe bradycardia with a decrease in cardiac output and syncope (Stoke-Adams attacks).10 Conclusion We present a case of congenital infra-Hisian AVB that was unique in presentation in fetal and postnatal life. This clinical presentation included an irregular heart rate in fetal life, rate-dependent AVB with proven unreliable escape rhythm in times of atrial tachycardia. Variability in the escape rhythm led to bouts of more profound bradycardia, worsened by isoproterenol, and associated with subtly worsened peripheral perfusion. It is critical for the clinician to recognize the potential for infra-Hisian block in patients such as this, owing to the risk of abrupt worsening of AV conduction at times of stress and the paradoxical response to isoproterenol. Disclosures The authors have no conflicts of interest to disclose.